Search details
1.
Cariprazine as a maintenance therapy in the prevention of mood episodes in adults with bipolar I disorder.
Bipolar Disord
; 2024 Apr 12.
Article
in English
| MEDLINE | ID: mdl-38609342
2.
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
Bipolar Disord
; 22(4): 372-384, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31628698
3.
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting ß2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.
Am J Respir Crit Care Med
; 194(5): 559-67, 2016 09 01.
Article
in English
| MEDLINE | ID: mdl-27585384
4.
Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials.
Int Clin Psychopharmacol
; 2024 Jan 25.
Article
in English
| MEDLINE | ID: mdl-38277187
5.
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Antimicrob Agents Chemother
; 57(4): 1777-83, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23357764
6.
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Am J Psychiatry
; 180(3): 241-251, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36789515
7.
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
J Clin Psychiatry
; 84(5)2023 08 16.
Article
in English
| MEDLINE | ID: mdl-37585254
8.
A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression.
J Affect Disord
; 263: 386-395, 2020 02 15.
Article
in English
| MEDLINE | ID: mdl-31969269
9.
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Am J Psychiatry
; 176(6): 439-448, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-30845817
10.
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.
Open Forum Infect Dis
; 6(4): ofz149, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-31041348
11.
Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years.
J Cardiovasc Pharmacol Ther
; 13(4): 241-51, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-18832343
12.
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.
NPJ Prim Care Respir Med
; 25: 15018, 2015 Apr 30.
Article
in English
| MEDLINE | ID: mdl-25927321
13.
ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.
Clin Drug Investig
; 33(12): 893-904, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24085591
14.
Preference, satisfaction and errors with two dry powder inhalers in patients with COPD.
Expert Opin Drug Deliv
; 10(8): 1023-31, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23745954
15.
Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects.
Eur Urol
; 50(2): 317-26, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16687205
Results
1 -
15
de 15
1
Next >
>>